研究含有胺基生物异构体的Hsp90C-终端抑制剂
Eva Amatya1, Chitra Subramanian2, Reagan Long1
1Department of Chemistry and Biochemistry, Warren Family Research Center for Drug Discovery and Development, University of Notre Dame, Notre Dame, Indiana, 46556, USA.
ChemMedChem
|August 17, 2024
概括
研究人员开发了用于治疗黑色素瘤的新型热冲击蛋白90 (Hsp90) C终端抑制剂. 这些化合物对突变和野生型BRAF黑色素瘤细胞都表现出抗增殖活性,这表明它们具有治疗潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药用化学 医学化学
背景情况:
- 热冲击蛋白90 (Hsp90) 对许多客户端蛋白质的稳定性和功能至关重要,其中许多与癌症发展有关.
- Hsp90在多种致癌途径中的作用使其成为一个有前途的治疗点,特别是在黑色素瘤中.
- 抑制Hsp90可以同时破坏几个促进癌症的途径,为有效治疗提供了潜在的策略.
研究的目的:
- 合成和评估一系列新的Hsp90 C-终端抑制剂.
- 评估这些抑制剂对不同BRAF突变状态的黑色素瘤细胞系的抗增殖活性.
- 探索化合物的结构-活性关系 (SAR),重点是胺部分的修改.
主要方法:
- 合成了一系列新型的Hsp90 C-终端抑制剂.
- 使用IC50测定对黑色素瘤细胞系 (SKMel173,SKMel103,SKMel19,A375) 的抗增殖活性评估.
- 结构-活性关系研究涉及将胺生物异构体引入抑制剂 (化合物6).
主要成果:
- 合成的Hsp90 C终端抑制剂对黑色素瘤细胞表现出显著的抗增殖作用.
- 化合物6在不同细胞系中表现出强烈的活性,IC50值从0.607μM到1.413μM不等.
- SAR研究提供了关于优化抑制剂结构以提高疗效的见解.
结论:
- 新型的Hsp90 C终端抑制剂对黑色素瘤细胞具有显著的抗增殖活性.
- 开发的化合物,特别是化合物6,代表了进一步研究黑色素瘤治疗的有希望的候选者.
- 针对Hsp90提供了一种可行的策略,可以在癌症治疗中同时破坏多个致癌途径.
相关概念视频
Molecular Chaperones and Protein Folding
14.7K
The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...
The...
14.7K
Bacterial Protein Maturation
744
Bacterial protein maturation is a tightly regulated process that ensures newly synthesized polypeptides achieve correct functional conformations. This maturation involves a series of modifications, folding events, and quality control steps, often assisted by specialized chaperone proteins.N-Terminal ModificationsThe maturation of bacterial polypeptides begins cotranslationally as the polypeptide exits the ribosome. The first amino acid, N-formylmethionine (fMet), is typically modified at the...
744


